Top in ID: Monkeypox stigma; long COVID symptoms
As the monkeypox case count climbs in the United States, experts warned about the consequences of stigmatizing language, which could discourage patients from seeking treatment.
In a joint statement, the Infectious Diseases Society of America and HIV Medicine Association expressed concern over the use of “racist and homophobic language” regarding the growing outbreak and said the disease is not exclusive to any specific population. It was the top story in infectious disease last week.
Another top story was about the prevalence of long COVID symptoms. A recent study found that up to one in four adults who had COVID-19 experience at least one symptom of long COVID, the most common being acute pulmonary embolism and respiratory symptoms.
Read the top stories in infectious disease below:
Monkeypox updates: US case count climbs to nine as experts warn about stigma
Healio is tracking updates on the widening outbreak of monkeypox. Read more.
Up to 1 in 4 adult survivors experience at least one long COVID symptom
COVID-19 survivors face a significantly higher risk than control patients for developing conditions affecting major system of the body, according to a study of nearly 2 million patients. Read more.
HIV an independent risk factor for nonalcoholic steatohepatitis
A study of more than 1,300 women demonstrated that HIV is an independent risk factor for nonalcoholic steatohepatitis with significant nonalcoholic fatty liver disease activity and fibrosis, researchers reported. Read more.
Another study adds evidence that HIV may be risk factor for severe COVID-19
HIV was an independent risk factor for severe COVID-19 at hospital admission and in-hospital mortality in a study that included nearly 200,000 patients from dozens of countries. Read more.
No substantial changes in C. difficile trends early in pandemic
Despite the changes and disruptions to care caused by COVID-19, researchers found that there were no significant changes in the incidence of Clostridioides difficile during the first year of the pandemic. Read more.